Intracranial Vascular Procedures DRG 022 Reimbursement

DRG 022 encompasses intracranial vascular procedures for patients whose principal diagnosis is hemorrhage without Complication or Comorbidity or Major Complication or Comorbidity, covering surgical and endovascular treatments. Proper assignment is important for inpatient reimbursement because it determines the Diagnosis-Related Group grouping that drives Medicare hospital payment for these resource-intensive neurosurgical admissions.

DRG 022 Overview

DRG 022 covers inpatient cases for intracranial vascular procedures performed with a principal diagnosis of hemorrhage and without Complication or Comorbidity or Major Complication or Comorbidity. This category includes surgical and endovascular interventions aimed at controlling or repairing intracranial bleeding sources. It matters for Medicare payment because classification into this Diagnosis-Related Group determines base payment weights and impacts hospital reimbursement for these high-acuity neurosurgical admissions. Accurate coding of the principal diagnosis and any comorbid conditions directly affects payment assignment.

Acute endovascular procedure trials assessing timing and technique optimization for patients with intracranial hemorrhage undergoing vascular interventions: These studies focus on immediate perioperative approaches such as choice of access route, device deployment strategies, and short-term hemostatic or procedural adjuncts in adults admitted with intracranial hemorrhage who require intracranial vascular procedures. They evaluate endpoints like procedure-related complication rates, intraprocedural bleeding control, and 30-day neurological outcomes to inform best practices during the index hospitalization. Findings are relevant to providers and payers because they impact in-hospital resource use, complication-related costs, and short-term length of stay for this high-acuity DRG population.
Comparative effectiveness research comparing procedural versus conservative or alternative minimally invasive management strategies in subpopulations without major comorbidities: These observational cohort studies or pragmatic randomized designs enroll patients with primary intracranial hemorrhage but without CC/MCC to compare outcomes of different vascular procedural approaches (for example, open microsurgical clipping, endovascular embolization, or stereotactic minimally invasive drainage) across matched clinical profiles. They measure medium-term functional outcomes, readmission rates, and procedure-related morbidity to determine which strategies offer the best balance of effectiveness and safety in patients who are relatively healthier at baseline. Such evidence helps clinicians optimize procedure selection and helps payers and health systems predict cost-effectiveness and allocate resources for the most appropriate treatments in this DRG group.
Post-discharge recovery and health services outcomes studies evaluating rehabilitation needs, readmissions, and long-term functional trajectories after intracranial vascular procedures for hemorrhage: These longitudinal cohort studies follow patients discharged after intracranial vascular intervention without major comorbidities to quantify rehabilitation utilization, timing of return to baseline function, late complications, and health-related quality of life over months to years. They identify predictors of readmission, durable disability, and outpatient resource use, informing care pathways such as targeted discharge planning and early rehabilitation referral. For providers and payers, this research guides post-acute care planning, supports value-based care decisions, and helps forecast longer-term costs tied to this DRG beyond the index hospitalization.

Acute endovascular procedure trials assessing timing and technique optimization for patients with intracranial hemorrhage undergoing vascular interventions: These studies focus on immediate perioperative approaches such as choice of access route, device deployment strategies, and short-term hemostatic or procedural adjuncts in adults admitted with intracranial hemorrhage who require intracranial vascular procedures. They evaluate endpoints like procedure-related complication rates, intraprocedural bleeding control, and 30-day neurological outcomes to inform best practices during the index hospitalization. Findings are relevant to providers and payers because they impact in-hospital resource use, complication-related costs, and short-term length of stay for this high-acuity DRG population.
Comparative effectiveness research comparing procedural versus conservative or alternative minimally invasive management strategies in subpopulations without major comorbidities: These observational cohort studies or pragmatic randomized designs enroll patients with primary intracranial hemorrhage but without CC/MCC to compare outcomes of different vascular procedural approaches (for example, open microsurgical clipping, endovascular embolization, or stereotactic minimally invasive drainage) across matched clinical profiles. They measure medium-term functional outcomes, readmission rates, and procedure-related morbidity to determine which strategies offer the best balance of effectiveness and safety in patients who are relatively healthier at baseline. Such evidence helps clinicians optimize procedure selection and helps payers and health systems predict cost-effectiveness and allocate resources for the most appropriate treatments in this DRG group.
Post-discharge recovery and health services outcomes studies evaluating rehabilitation needs, readmissions, and long-term functional trajectories after intracranial vascular procedures for hemorrhage: These longitudinal cohort studies follow patients discharged after intracranial vascular intervention without major comorbidities to quantify rehabilitation utilization, timing of return to baseline function, late complications, and health-related quality of life over months to years. They identify predictors of readmission, durable disability, and outpatient resource use, informing care pathways such as targeted discharge planning and early rehabilitation referral. For providers and payers, this research guides post-acute care planning, supports value-based care decisions, and helps forecast longer-term costs tied to this DRG beyond the index hospitalization.

OpenPayer

Summary & Overview

Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage without CC/MCC: Inpatient Reimbursement Overview

DRG 022 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes